# DNA Capital

DNA Capital is a Family Office based in San Francisco, Hong Kong.

## Overview

- **Organization type:** Family Office
- **Headquarters:** San Francisco, Hong Kong
- **Region:** Asia
- **Address:** Hong Kong
- **Founded:** 2009
- **Assets under management:** Undisclosed
- **Website:** dnacap.fund
- **LinkedIn:** https://www.linkedin.com/company/dna-capital

## Regulatory record

- **CRD number:** 309478
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/309478

## About

DNA Capital traces to the Bueno family founders of Amil, a Brazilian health insurance and services group later acquired by UnitedHealth Group. Edson Bueno established the firm before his death; Pedro Bueno and Dulce Bueno continue as principals. The office is headquartered in Hong Kong. Investment activity centers on venture capital and management buyouts. Confirmed holdings include Consensys, Mysten Labs, and Neo4j. The portfolio also encompasses Rede Ímpar Hospital Network and DASA diagnostic operations in Brazil, plus UnitedHealth Group shares. Geographic reach spans Asia, Latin America, and the United States. No public headcount or AUM figures exist. The firm belongs to ABVCAP and LAVCA. Adjacent structures include the Bueno Family Foundation and Movimento Bem Maior. No operational events from the last 24 months appear in available records. DNA Capital operates as a single-family office with direct exposure to operating healthcare businesses in Brazil. This structure creates a distinct link between legacy asset ownership and new venture allocations.

## Sectors

- Venture
- Healthcare Services

## People

- Pedro Bueno — Partner
- Dulce Bueno — Co-founder
- Edson Bueno — Founder

## Questions

### Who runs investment decisions at DNA Capital?

Pedro Bueno serves as partner. Dulce Bueno acts as co-founder with prior involvement in Amil.

### Does DNA Capital participate in fund commitments or only direct deals?

The firm holds direct positions in Consensys, Mysten Labs, and Neo4j alongside operating assets in Brazil.

### What investment stages does DNA Capital typically target?

Activity includes venture capital and management buyouts.

### How is DNA Capital related to DASA?

Pedro Bueno serves as CEO of DASA while acting as partner at DNA Capital.

## Related profiles

- [DMZ Ventures](https://altss.com/profile/dmz-ventures)
- [DN Capital](https://altss.com/profile/dn-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/dna-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology